drug-information.ru

|Synalar Ointment Synalar Solution

Drugs search, click the first letter of a drug name:

| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9 Home

Synalar

Generic Name: fluocinolone acetonide
Dosage Form: Ointment

Rx Only

Synalar Description

Synalar® (fluocinolone acetonide) Ointment 0.025% is intended for topical administration. The active component is the corticosteroid fluocinolone acetonide, which has the chemical name pregna - 1,4 - diene - 3,20 - dione,6,9 - difluoro - 11,21 - dihydroxy - 16,17 - [(1 - methylethylidene)bis(oxy)] - ,(6α,11β,16α) - . It has the following chemical structure:

The ointment contains fluocinolone acetonide 0.25 mg/g in a white petrolium USP vehicle.

Synalar - Clinical Pharmacology

Topical corticosteroids share anti-inflammatory, anti-pruritic and vasoconstrictive actions.

The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man.

Pharmacokinetics

The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings.

Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase percutaneous absorption. Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids. Thus, occlusive dressings may be a valuable therapeutic adjunct for treat-ment of resistant dermatoses (see DOSAGE AND ADMINISTRATION).

Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Corticosteroids are bound to plasma proteins in varying degrees. Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys. Some of the topical corticosteroids and their metabolites are also excreted into the bile.

Indications and Usage for Synalar

Synalar Ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteriod-responsive dermatoses.

Contraindications

Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Precautions

General

Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing"s syndrome, hyperglycemia, and glucosuria in some patients.

Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings.

Therefore, patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests. If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent steroid.

Recovery of HPA axis function is generally prompt and complete upon discontinuation of the drug. Infrequently, signs and symptoms of steroid withdrawal may occur, requiring supplemental systemic corticosteroids.

Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity (see PRECAUTIONS— Pediatric Use).

If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted.

As with any topical corticosteroid product, prolonged use may produce atrophy of the skin and subcutaneous tissues. When used on intertriginous or flexor areas, or on the face, this may occur even with short-term use.

In the presence of dermatological infections, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.

Information for the Patient

Patients using topical corticosteroids should receive the following information and instructions:

This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes.
Patients should be advised not to use this medication for any disorder other than that for which it was prescribed.
The treated skin area should not be bandaged or otherwise covered or wrapped as to be occlusive unless directed by the physician.
Patients should report any signs of local adverse reactions, especially under occlusive dressing.
Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area, as these garments may constitute occlusive dressings.

Laboratory Tests

The following tests may be helpful in evaluating the HPA axis suppression:

: Urinary free cortisol test
: ACTH stimulation test

Carcinogenesis, Mutagenesis, and Impairment of Fertility

Long-term animal studies have not been performed to evaluate the carcinogenic potential or the effect on fertility of topical corticosteroids.

Studies to determine mutagenicity with prednisolone and hydrocortisone have revealed negative results.

Pregnancy Category C

Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels. The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.

Nursing Mothers

It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Systemically administered corticosteroids are secreted into breast milk in quantities not likely to have a deleterious effect on the infant. Nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman.

Pediatric Use

Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hypothalmic-pituitary-adrenal (HPA) axis suppression and Cushing"s syndrome than mature patients because of a larger skin surface area to body weight ratio.

HPA axis suppression, Cushing"s syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. Manifestations of adrenal suppression in children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to ACTH stimulation. Manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema.

Administration of topical corticosteroids to children should be limited to the least amount compatible with an effective therapeutic regimen. Chronic corticosteroid therapy may interfere with the growth and development of children.

Adverse Reactions

The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence:

Burning	Hypertrichosis	Maceration of the skin
Itching	Acneiform eruptions	Secondary infection
Irritation	Hypopigmentation	Skin atrophy
Dryness	Perioral dermatitis	Striae
Folliculitis	Allergic contact dermatitis	Miliaria

Overdosage

Topically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects (see PRECAUTIONS).

Synalar Dosage and Administration

Synalar Ointment is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. In hairy sites, the hair should be parted to allow direct contact with the lesion.

Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions. Some plastic films may be flammable and due care should be exercised in their use. Similarly, caution should be employed when such films are used on children or left in their proximity, to avoid the possibility of accidental suffocation.

If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

How is Synalar Supplied

Synalar® (fluocinolone acetonide) Ointment 0.025% is supplied in

: 15 g Tube –NDC 99207-504-13
: 60 g Tube –NDC 99207-504-17

Store at room temperature; avoid freezing and excessive heat above 40°C (104°F).

Manufactured for:
MEDICIS, The Dermatology Company®
Scottsdale, AZ 85258

IN-5068/S

Synalar (fluocinolone acetonide)

PRODUCT INFO
Product Code	99207-504	Dosage Form	OINTMENT
Route Of Administration	TOPICAL	DEA Schedule

INGREDIENTS
Name (Active Moiety)	Type	Strength
fluocinolone acetonide (fluocinolone)	Active	0.25 MILLIGRAM In 1 GRAM
white petroleum	Inactive

IMPRINT INFORMATION
Characteristic	Appearance	Characteristic	Appearance
Color		Score
Shape		Symbol
Imprint Code		Coating
Size

PACKAGING
#	NDC	Package Description	Multilevel Packaging
1	99207-504-13	15 GRAM In 1 TUBE	None
2	99207-504-17	60 GRAM In 1 TUBE	None

Revised: 08/2006

Where can I get more information about Synalar Ointment Synalar Solution ? We recommend to use www.Drugs.com

Typical mistypes for Synalar Ointment Synalar Solution
aynalar ointment synalar solution, zynalar ointment synalar solution, xynalar ointment synalar solution, dynalar ointment synalar solution, eynalar ointment synalar solution, wynalar ointment synalar solution, stnalar ointment synalar solution, sgnalar ointment synalar solution, shnalar ointment synalar solution, sunalar ointment synalar solution, s7nalar ointment synalar solution, s6nalar ointment synalar solution, sybalar ointment synalar solution, symalar ointment synalar solution, syjalar ointment synalar solution, syhalar ointment synalar solution, synzlar ointment synalar solution, synslar ointment synalar solution, synwlar ointment synalar solution, synqlar ointment synalar solution, synakar ointment synalar solution, synapar ointment synalar solution, synaoar ointment synalar solution, synalzr ointment synalar solution, synalsr ointment synalar solution, synalwr ointment synalar solution, synalqr ointment synalar solution, synalae ointment synalar solution, synalad ointment synalar solution, synalaf ointment synalar solution, synalat ointment synalar solution, synala5 ointment synalar solution, synala4 ointment synalar solution, synalar iintment synalar solution, synalar kintment synalar solution, synalar lintment synalar solution, synalar pintment synalar solution, synalar 0intment synalar solution, synalar 9intment synalar solution, synalar ountment synalar solution, synalar ojntment synalar solution, synalar okntment synalar solution, synalar oontment synalar solution, synalar o9ntment synalar solution, synalar o8ntment synalar solution, synalar oibtment synalar solution, synalar oimtment synalar solution, synalar oijtment synalar solution, synalar oihtment synalar solution, synalar oinrment synalar solution, synalar oinfment synalar solution, synalar oingment synalar solution, synalar oinyment synalar solution, synalar oin6ment synalar solution, synalar oin5ment synalar solution, synalar ointnent synalar solution, synalar ointkent synalar solution, synalar ointjent synalar solution, synalar ointmwnt synalar solution, synalar ointmsnt synalar solution, synalar ointmdnt synalar solution, synalar ointmrnt synalar solution, synalar ointm4nt synalar solution, synalar ointm3nt synalar solution, synalar ointmebt synalar solution, synalar ointmemt synalar solution, synalar ointmejt synalar solution, synalar ointmeht synalar solution, synalar ointmenr synalar solution, synalar ointmenf synalar solution, synalar ointmeng synalar solution, synalar ointmeny synalar solution, synalar ointmen6 synalar solution, synalar ointmen5 synalar solution, synalar ointment aynalar solution, synalar ointment zynalar solution, synalar ointment xynalar solution, synalar ointment dynalar solution, synalar ointment eynalar solution, synalar ointment wynalar solution, synalar ointment stnalar solution, synalar ointment sgnalar solution, synalar ointment shnalar solution, synalar ointment sunalar solution, synalar ointment s7nalar solution, synalar ointment s6nalar solution, synalar ointment sybalar solution, synalar ointment symalar solution, synalar ointment syjalar solution, synalar ointment syhalar solution, synalar ointment synzlar solution, synalar ointment synslar solution, synalar ointment synwlar solution, synalar ointment synqlar solution, synalar ointment synakar solution, synalar ointment synapar solution, synalar ointment synaoar solution, synalar ointment synalzr solution, synalar ointment synalsr solution, synalar ointment synalwr solution, synalar ointment synalqr solution, synalar ointment synalae solution, synalar ointment synalad solution, synalar ointment synalaf solution, synalar ointment synalat solution, synalar ointment synala5 solution, synalar ointment synala4 solution, synalar ointment synalar aolution, synalar ointment synalar zolution, synalar ointment synalar xolution, synalar ointment synalar dolution, synalar ointment synalar eolution, synalar ointment synalar wolution, synalar ointment synalar silution, synalar ointment synalar sklution, synalar ointment synalar sllution, synalar ointment synalar splution, synalar ointment synalar s0lution, synalar ointment synalar s9lution, synalar ointment synalar sokution, synalar ointment synalar sopution, synalar ointment synalar sooution, synalar ointment synalar solytion, synalar ointment synalar solhtion, synalar ointment synalar soljtion, synalar ointment synalar solition, synalar ointment synalar sol8tion, synalar ointment synalar sol7tion, synalar ointment synalar solurion, synalar ointment synalar solufion, synalar ointment synalar solugion, synalar ointment synalar soluyion, synalar ointment synalar solu6ion, synalar ointment synalar solu5ion, synalar ointment synalar solutuon, synalar ointment synalar solutjon, synalar ointment synalar solutkon, synalar ointment synalar solutoon, synalar ointment synalar solut9on, synalar ointment synalar solut8on, synalar ointment synalar solutiin, synalar ointment synalar solutikn, synalar ointment synalar solutiln, synalar ointment synalar solutipn, synalar ointment synalar soluti0n, synalar ointment synalar soluti9n, synalar ointment synalar solutiob, synalar ointment synalar solutiom, synalar ointment synalar solutioj, synalar ointment synalar solutioh, ynalar ointment synalar solution, snalar ointment synalar solution, syalar ointment synalar solution, synlar ointment synalar solution, synaar ointment synalar solution, synalr ointment synalar solution, synala ointment synalar solution, synalarointment synalar solution, synalar intment synalar solution, synalar ontment synalar solution, synalar oitment synalar solution, synalar oinment synalar solution, synalar ointent synalar solution, synalar ointmnt synalar solution, synalar ointmet synalar solution, synalar ointmen synalar solution, synalar ointment synalar solution, synalar ointment synalar solution, synalar ointment ynalar solution, synalar ointment snalar solution, synalar ointment syalar solution, synalar ointment synlar solution, synalar ointment synaar solution, synalar ointment synalr solution, synalar ointment synala solution, synalar ointment synalarsolution, synalar ointment synalar olution, synalar ointment synalar slution, synalar ointment synalar soution, synalar ointment synalar soltion, synalar ointment synalar soluion, synalar ointment synalar soluton, synalar ointment synalar solutin, synalar ointment synalar solutio, ysnalar ointment synalar solution, snyalar ointment synalar solution, syanlar ointment synalar solution, synlaar ointment synalar solution, synaalr ointment synalar solution, synalra ointment synalar solution, synala rointment synalar solution, synalaro intment synalar solution, synalar iontment synalar solution, synalar onitment synalar solution, synalar oitnment synalar solution, synalar oinmtent synalar solution, synalar ointemnt synalar solution, synalar ointmnet synalar solution, synalar ointmetn synalar solution, synalar ointmen t synalar solution, synalar ointment synalar solution, synalar ointment s ynalar solution, synalar ointment ysnalar solution, synalar ointment snyalar solution, synalar ointment syanlar solution, synalar ointment synlaar solution, synalar ointment synaalr solution, synalar ointment synalra solution, synalar ointment synala rsolution, synalar ointment synalars olution, synalar ointment synalar oslution, synalar ointment synalar sloution, synalar ointment synalar soultion, synalar ointment synalar soltuion, synalar ointment synalar soluiton, synalar ointment synalar solutoin, synalar ointment synalar solutino, ssynalar ointment synalar solution, syynalar ointment synalar solution, synnalar ointment synalar solution, synaalar ointment synalar solution, synallar ointment synalar solution, synalaar ointment synalar solution, synalarr ointment synalar solution, synalar ointment synalar solution, synalar oointment synalar solution, synalar oiintment synalar solution, synalar oinntment synalar solution, synalar ointtment synalar solution, synalar ointmment synalar solution, synalar ointmeent synalar solution, synalar ointmennt synalar solution, synalar ointmentt synalar solution, synalar ointment synalar solution, synalar ointment synalar solution, synalar ointment ssynalar solution, synalar ointment syynalar solution, synalar ointment synnalar solution, synalar ointment synaalar solution, synalar ointment synallar solution, synalar ointment synalaar solution, synalar ointment synalarr solution, synalar ointment synalar solution, synalar ointment synalar ssolution, synalar ointment synalar soolution, synalar ointment synalar sollution, synalar ointment synalar soluution, synalar ointment synalar soluttion, synalar ointment synalar solutiion, synalar ointment synalar solutioon, synalar ointment synalar solutionn, etc.